It's funny: in that article the company's management also says it is unaware of any similar compounds in clinical trials. They are apparently unaware of Kevetrin or its Phase 1! So odd to me. These guys all work in a vacuum? Forget research conferences, articles, peer interaction... how about a ten second search on Google??
Market Data 
Markets 
AI
